vs
Side-by-side financial comparison of EyePoint, Inc. (EYPT) and Identiv, Inc. (INVE). Click either name above to swap in a different company.
Identiv, Inc. is the larger business by last-quarter revenue ($6.2M vs $5.3M, roughly 1.2× EyePoint, Inc.). Identiv, Inc. runs the higher net margin — -60.3% vs -1114.3%, a 1054.0% gap on every dollar of revenue. On growth, Identiv, Inc. posted the faster year-over-year revenue change (-7.9% vs -43.7%). Identiv, Inc. produced more free cash flow last quarter ($2.8M vs $-63.8M). Over the past eight quarters, Identiv, Inc.'s revenue compounded faster (-3.8% CAGR vs -40.8%).
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
Identiv is a publicly traded Internet of Things technology company listed on the Nasdaq stock market.
EYPT vs INVE — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.3M | $6.2M |
| Net Profit | $-59.4M | $-3.7M |
| Gross Margin | — | 18.1% |
| Operating Margin | -1166.8% | -76.4% |
| Net Margin | -1114.3% | -60.3% |
| Revenue YoY | -43.7% | -7.9% |
| Net Profit YoY | -92.8% | -948.2% |
| EPS (diluted) | $-0.85 | $-0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $6.2M | ||
| Q3 25 | — | $5.0M | ||
| Q2 25 | $5.3M | $5.0M | ||
| Q1 25 | $24.5M | $5.3M | ||
| Q4 24 | $11.6M | $6.7M | ||
| Q3 24 | $10.5M | $6.5M | ||
| Q2 24 | $9.5M | $6.7M | ||
| Q1 24 | $11.7M | $6.7M |
| Q4 25 | — | $-3.7M | ||
| Q3 25 | — | $-3.5M | ||
| Q2 25 | $-59.4M | $-6.0M | ||
| Q1 25 | $-45.2M | $-4.8M | ||
| Q4 24 | $-41.4M | $-355.0K | ||
| Q3 24 | $-29.4M | $85.9M | ||
| Q2 24 | $-30.8M | $-6.2M | ||
| Q1 24 | $-29.3M | $-4.6M |
| Q4 25 | — | 18.1% | ||
| Q3 25 | — | 10.7% | ||
| Q2 25 | — | -9.4% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | — | -14.9% | ||
| Q3 24 | 93.0% | 3.6% | ||
| Q2 24 | 85.2% | 9.1% | ||
| Q1 24 | 93.5% | 7.3% |
| Q4 25 | — | -76.4% | ||
| Q3 25 | — | -111.4% | ||
| Q2 25 | -1166.8% | -126.7% | ||
| Q1 25 | -199.7% | -103.8% | ||
| Q4 24 | -390.4% | -98.9% | ||
| Q3 24 | -311.2% | -146.2% | ||
| Q2 24 | -364.5% | -99.7% | ||
| Q1 24 | -285.2% | -76.0% |
| Q4 25 | — | -60.3% | ||
| Q3 25 | — | -68.9% | ||
| Q2 25 | -1114.3% | -119.9% | ||
| Q1 25 | -184.8% | -90.9% | ||
| Q4 24 | -357.3% | -5.3% | ||
| Q3 24 | -279.0% | 1315.8% | ||
| Q2 24 | -325.3% | -92.2% | ||
| Q1 24 | -250.6% | -68.5% |
| Q4 25 | — | $-0.17 | ||
| Q3 25 | — | $-0.15 | ||
| Q2 25 | $-0.85 | $-0.26 | ||
| Q1 25 | $-0.65 | $-0.21 | ||
| Q4 24 | $-0.65 | $0.00 | ||
| Q3 24 | $-0.54 | $3.62 | ||
| Q2 24 | $-0.58 | $-0.27 | ||
| Q1 24 | $-0.55 | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $255.7M | $128.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $246.0M | $140.7M |
| Total Assets | $301.1M | $151.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $128.6M | ||
| Q3 25 | — | $126.3M | ||
| Q2 25 | $255.7M | $129.3M | ||
| Q1 25 | $318.2M | $132.4M | ||
| Q4 24 | $370.9M | $135.6M | ||
| Q3 24 | $253.8M | $145.4M | ||
| Q2 24 | $280.2M | $18.4M | ||
| Q1 24 | $299.3M | $21.6M |
| Q4 25 | — | $140.7M | ||
| Q3 25 | — | $143.7M | ||
| Q2 25 | $246.0M | $146.4M | ||
| Q1 25 | $298.4M | $150.5M | ||
| Q4 24 | $336.5M | $154.1M | ||
| Q3 24 | $218.7M | $156.7M | ||
| Q2 24 | $228.3M | $65.1M | ||
| Q1 24 | $249.9M | $70.2M |
| Q4 25 | — | $151.3M | ||
| Q3 25 | — | $151.0M | ||
| Q2 25 | $301.1M | $153.9M | ||
| Q1 25 | $362.6M | $158.7M | ||
| Q4 24 | $418.5M | $163.2M | ||
| Q3 24 | $300.9M | $177.0M | ||
| Q2 24 | $324.2M | $97.8M | ||
| Q1 24 | $329.2M | $101.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-62.6M | $3.0M |
| Free Cash FlowOCF − Capex | $-63.8M | $2.8M |
| FCF MarginFCF / Revenue | -1196.5% | 45.8% |
| Capex IntensityCapex / Revenue | 22.9% | 3.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-194.0M | $-7.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $3.0M | ||
| Q3 25 | — | $-2.9M | ||
| Q2 25 | $-62.6M | $-3.6M | ||
| Q1 25 | $-53.1M | $-3.3M | ||
| Q4 24 | $-35.8M | $-5.9M | ||
| Q3 24 | $-39.0M | $-7.2M | ||
| Q2 24 | $-20.2M | $-993.0K | ||
| Q1 24 | $-31.2M | $-1.3M |
| Q4 25 | — | $2.8M | ||
| Q3 25 | — | $-3.2M | ||
| Q2 25 | $-63.8M | $-3.8M | ||
| Q1 25 | $-53.4M | $-3.6M | ||
| Q4 24 | $-36.2M | $-6.5M | ||
| Q3 24 | $-40.6M | $-7.7M | ||
| Q2 24 | $-21.1M | $-1.1M | ||
| Q1 24 | $-32.4M | $-1.5M |
| Q4 25 | — | 45.8% | ||
| Q3 25 | — | -64.5% | ||
| Q2 25 | -1196.5% | -75.8% | ||
| Q1 25 | -218.4% | -68.0% | ||
| Q4 24 | -312.7% | -97.7% | ||
| Q3 24 | -385.8% | -118.2% | ||
| Q2 24 | -222.4% | -16.7% | ||
| Q1 24 | -277.0% | -23.0% |
| Q4 25 | — | 3.3% | ||
| Q3 25 | — | 7.0% | ||
| Q2 25 | 22.9% | 5.0% | ||
| Q1 25 | 1.1% | 5.7% | ||
| Q4 24 | 3.3% | 9.3% | ||
| Q3 24 | 15.0% | 7.7% | ||
| Q2 24 | 9.5% | 2.0% | ||
| Q1 24 | 10.2% | 3.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -0.08× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EYPT
Segment breakdown not available.
INVE
| Other | $3.4M | 55% |
| Europe And Middle East | $2.2M | 36% |
| Asia Pacific | $575.0K | 9% |
